Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new Oxford consortium to develop novel therapies for Tuberculosis

2 March 2026

Speaking at the event, 'The Nobel Prize to Now: building a legacy of discovery to tackle AMR', Prof McShane reflects on why we so urgently need new antibiotics to treat drug-resistant tuberculosis, and how therapeutic vaccines can be used to combat the world's most devastating pathogen. To tackle this global health threat, the IOI has awarded £5m for the establishment of an Oxford consortium to develop new therapies for TB.

Watch Prof McShane talk here: IOI Grand Challenge: Tuberculosis

Read more about the IOI Grand Challenge here ➡️
https://www.ineosoxford.ox.ac.uk/ioi-grand-challenge-tuberculosis